Beal Anne's most recent trade in GSK Plc - ADR was a trade of 70 Ords 0.31p done at an average price of $26.4 . Disclosure was reported to the exchange on July 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 26.37 per share. | 10 Jul 2026 | 70 | 9,958 (0%) | 0% | 26.4 | 1,846 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 25.35 per share. | 22 Jun 2026 | 1,490 | 9,888 (0%) | 0% | 25.3 | 37,765 | Ords 0.31p |
| Omada Health Inc | Anne Beal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 10,882 | 20,618 | - | 0 | Common Stock | |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 29.47 per share. | 09 Apr 2026 | 64 | 8,398 (0%) | 0% | 29.5 | 1,886 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 25.90 per share. | 20 Mar 2026 | 392 | 8,334 (0%) | 0% | 25.9 | 10,152 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 24.28 per share. | 19 Dec 2025 | 402 | 10,844 (0%) | 0% | 24.3 | 9,760 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 21.87 per share. | 10 Oct 2025 | 68 | 10,442 (0%) | 0% | 21.9 | 1,487 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.37 per share. | 19 Sep 2025 | 480 | 10,374 (0%) | 0% | 20.4 | 9,777 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 70 | 9,894 (0%) | 0% | 19.3 | 1,349 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 18.95 per share. | 20 Jun 2025 | 514 | 9,824 (0%) | 0% | 18.9 | 9,739 | Ords 0.31p |
| Omada Health Inc | Anne Beal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 9,736 | 9,736 | - | 0 | Common Stock | |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 17.07 per share. | 11 Apr 2025 | 44 | 9,310 (0%) | 0% | 17.1 | 751 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 38.81 per share. | 25 Mar 2025 | 970 | 9,266 (0%) | 0% | 38.8 | 37,641 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 498 | 8,296 (0%) | 0% | 19.6 | 9,779 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Sale or transfer of securities back to the company at price $ 16.67 per share. | 10 Jan 2025 | 36 | 7,626 (0%) | 0% | 16.7 | 600 | Ords 0.31p |
| GSK PLC (ADR) | Beal Anne | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 542 | 7,590 (0%) | 0% | 16.9 | 9,162 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.54 per share. | 11 Oct 2024 | 28 | 7,048 (0%) | 0% | 19.5 | 547 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 448 | 7,020 (0%) | 0% | 20.5 | 9,187 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.67 per share. | 12 Jul 2024 | 24 | 6,572 (0%) | 0% | 19.7 | 472 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 450 | 6,548 (0%) | 0% | 20.4 | 9,172 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 12 Apr 2024 | 18 | 6,098 (0%) | 0% | 20.5 | 369 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 438 | 6,080 (0%) | 0% | 21.0 | 9,177 | Ords 0.31p |
| GSK PLC (ADR) | Anne Beal | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.08 per share. | 12 Jan 2024 | 12 | 5,480 (0%) | 0% | 20.1 | 241 | Ords 0.31p |